$1.15
2.68%
Nasdaq, Sep 28, 04:00 pm EDT.
ISIN
US87166L1008
Symbol
SYBX
Reports
Quarter | Annual
Index
NASDAQ Composite
Sector
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology

Synlogic Inc Stock News

Neutral
Synlogic Inc
●
Business Wire
●
2 months ago
Synlogic and Caldera Therapeutics Announce Merger Agreement and Concurrent Private Placement
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Synlogic, Inc. (OTC: SYBX) (“Synlogic”) and Caldera Therapeutics, Inc. (“Caldera”), a privately held clinical-stage biotechnology company developing CLD-423, a potential first-in-class TL1A x IL-23p19 bispecific antibody for inflammatory bowel disease (IBD) and other immune-mediated diseases, today announced that they have entered into a definitive merger agre...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now
The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today